Companies like Pfizer and Moderna are shifting their focus to younger age groups, preparing to test their vaccines on kids as young as 12.
Chapel Hill, N.C. — Companies like Pfizer and Moderna, who have been working on a COVID-19 vaccine, are shifting their focus to younger age groups, preparing to test their vaccines on kids as young as 12. The Pfizer and Moderna vaccine trials have shown promising results with over 90% effectiveness among adults. “We are going to be asleep at the wheel on this issue if we don’t think about children,” said Dr. Gavin Yamey, a global health and public policy professor. “While the mortality is less among children than among adults, I have seen COVID at it’s worst among children, and we have had a lot of cases here at UNC. We know what COVID can do,” said Dr. Payton Thompson, a pediatric infectious disease specialist at UNC.
